Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Extended Protocol of Evaluation of Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Two-Sided Pneumonia

NCT04602442 is registered in ClinicalTrials.gov with Olga Tyumina as lead sponsor.

NCT NCT04602442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04602442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Extended Protocol of Evaluation of Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Two-Sided Pneumonia
Lead sponsor
Olga Tyumina
Phase
Phase 2
Overall status
Unknown status
Start date
October 1, 2020
Completion date
December 30, 2021
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, covid19, sars-cov-2 pneumonia